MedPath

DS-8500a midazolam DDI study

Phase 1
Conditions
Healthy volunteers
Registration Number
JPRN-jRCT2080222622
Lead Sponsor
DAIICHISANKYO Co.,Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
28
Inclusion Criteria

1) Japanese
2) Between the age of 20 and 45
3) Between the BMI of 18.5 and 25.0
4) HbA1c < 6.5%
5) Between the fasting blood glucose level of 70 mg/dL and 109 mg/d

Exclusion Criteria

1) Presence or history of severe adverse reaction to any drug including midazolam or sensitivity.
2) Presence or history of drug or alcohol abuse. etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The PK parameters of midazolam
Secondary Outcome Measures
NameTimeMethod
1) Other PK parameters of free form and metabolites of midazolam<br>2) The PK parameters of DS-8500a<br>3) Safety
Âİ Copyright 2025. All Rights Reserved by MedPath